Elicio Therapeutics, IncElicio Therapeutics, IncElicio Therapeutics, Inc

Elicio Therapeutics, Inc

No trades
See on Supercharts

Price target

13.070.000.00%
The 2 analysts offering 1 year price forecasts for 9HA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to 9HA in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


9HA EPS for the last quarter is −0.56 EUR despite the estimation of −0.58 EUR. In the next quarter EPS is expected to reach −0.47 EUR. Track more of Elicio Therapeutics, Inc financials and stay on top of what is up with the company.
In the next quarter Elicio Therapeutics, Inc revenue is expected to reach 0.00 EUR. Check out Elicio Therapeutics, Inc revenue and earnings and make informed decisions.
According to analysts, 9HA price target is 13.07 EUR with a max estimate of 15.18 EUR and a min estimate of 10.96 EUR. Check if this forecast comes true in a year, meanwhile watch Elicio Therapeutics, Inc stock price chart and keep track of the current situation with 9HA news and stock market news.